A Defining Milestone for Gene Solutions: SPOT-MAS Multi-Cancer Screening Test Receives U.S. FDA Breakthrough Device Designation
- Written by Reporters
HONG KONG SAR - Media OutReach Newswire - 22 July 2026 - Gene Solutions – a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, announced that SPOT-MAS 10 has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This designation marks an...